Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2021
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell CarcinomaZeynep B Zengin, Caroline Weipert, Nicholas J Salgia, et al.
Nutrients|June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic TherapyHedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
Clinical Genitourinary Cancer|November 21, 2022
Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell CarcinomaAkram M Shayeb, Hannah Dzimitrowicz McManus, Danielle Urman, et al.
Cancer|March 26, 2020
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA resultsSumanta K Pal, Dean Bajorin, Nazli Dizman, et al.
JAMA Network Open|April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care CentersHedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
Journal for Immunotherapy of Cancer|May 5, 2026
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinomaAmeish Govindarajan, Nathaniel Hansen, Benjamin D Mercier, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
European Urology|August 26, 2019
First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database ConsortiumShaan Dudani, Jeffrey Graham, J Connor Wells, et al.
The Oncologist|March 27, 2023
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort AnalysisLuis Meza, Zeynep Zengin, Sabrina Salgia, et al.
Pageof 7